TransCode Therapeutics to present at AACR Annual Meeting 202

BOSTON, April 06, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it will... | April 6, 2023

Related Keywords

Massachusetts , United States , Boston , American , Susan Duggan , Alan Freidman , Zdravka Medarova , Transcode Therapeutics Inc , Cancer Research , Division Of Gastrointestinal , Nasdaq , Testing Of The Company , Belinda Termeer Center , Exchange Commission , American Association Of Cancer Research , Harvard Medical School , Athinoulaa Martinos Center , Oncology Company , Code Therapeutics , First In Human Clinical Trials , Progress Session , Annual Meeting , Poster Sessions , Transcode Therapeutics , Biomedical Imaging , Oncologic Surgery , Massachusetts General Hospital , Harvard Medical , Targeted Therapies , First In Human Study , Private Securities Litigation Reform Act , Investigational New Drug , Annual Report , Nc Stock Exchange , News , Information , Press Release , Pril , 023 , Transcode , The , Na , Ncology , O , More , Ffectively , Reating , Dancer , Sing , Oday , Nnounced , Hat , T Rnaz Us89357l1052 ,